FDA approves generic versions of blood thinner Plavix
date:May 18, 2012
Clopidogrel is FDA-approved to treat patients who have had a recent heart attack or a recent stroke, or have partial or total blockage of an artery (peripheral artery disease).


For people who must manage chronic health conditions, having effective and affordable treatment options is important, said Keith Webber, Ph.D., deputy director of the Office of Pharmaceutical Science in the FDAs Center for Drug Evaluation and Research. The generic products approved today will expand those options for pa
1/5 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/07 13:08